ORGANIZATIONAL AND METHODOLOGICAL APPROACHES TO IMPROVING DRUG PROVISION FOR PATIENTS WITH SOCIALLY SIGNIFICANT DISEASES
Main Article Content
Abstract
Drug provision for patients with socially significant diseases (SPD) is an important area of the Russian healthcare system that determines not only clinical outcomes, but also the socio-economic well-being of society. The article analyzes the existing problems in the drug supply system in the SPZ, such as regional disparities, shortages of individual drugs, and administrative barriers.
Based on a systematic approach, a set of organizational and methodological measures aimed at increasing the availability, effectiveness and rationality of pharmacotherapy is proposed. Key proposals include: the development of an electronic prescription and telemedicine consultation system; the creation of a real-time drug inventory monitoring system; and the introduction of treatment adherence (compliance) support programs based on interdisciplinary collaboration. The implementation of these approaches will optimize budget expenditures, improve the quality and life expectancy of patients with SPZ, and reduce the long-term epidemiological burden.
The aim of the research – development of a set of organizational and methodological approaches to improve the effectiveness, accessibility and rationality of drug provision for patients with socially significant diseases.
Results. Improving drug provision for socially significant diseases requires a comprehensive organizational and methodological approach that goes beyond simply increasing funding. The proposed package of measures, including digitalization, unification of regulations based on evidence-based medicine, the introduction of flexible financial mechanisms and the development of patient-oriented services, is aimed at creating a sustainable, fair and efficient system. A key condition for success is the synchronization of efforts at the federal and regional levels, as well as the active involvement of the professional medical and patient communities in the decision-making process.
The implementation of these approaches will make it possible to move from a cost compensation model to a treatment outcome management model, which will ultimately improve the quality of life of patients with socially significant diseases and reduce the long-term burden on the healthcare system.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
1. Agafonova YuA, Fedyaev DV, Omelyanovskiy VV, Snegovoy AV. Continuity of outpatient and inpatient drug supply of cancer patients – problems and solutions. Medical Technologies. Assessment and Choice. 2021; 43(3): 37-44. Russian (Агафонова Ю.А., Федяев Д.В., Омельяновский В.В., Снеговой А.В. Преемственность лекарственного обеспечения на амбулаторном и стационарном этапах терапии онкологических пациентов. Проблемы и пути решения //Медицинские технологии. Оценка и выбор. 2021. Т. 43, № 3. С. 37-44.) doi: 10.17116/medtech20214303137
2. Barkaev GS, Kabakova TI, Goryachev AB. Cluster analysis of integrated «drug supply» concept. Pharmacy & Pharmacology. 2022; 10(3): 232-243. Russian (Баркаев Г.С., Кабакова Т.И., Горячев А.Б. Кластерный анализ комплексного понятия «лекарственное обеспечение» //Фармация и фармакология. 2022. Т. 10, № 3. С. 232-243.) doi: 10.19163/2307-9266-2022-10-3-232-243
3. Linnik SA. Strategy of the health authorities of the subjects of the Russian Federation on the preferential medication provision for patients with malignant neoplasms. Public health and health care. 2023; 2: 32-36. Russian (Линник С.А. Стратегия органов управления здравоохранением субъектов Российской Федерации по льготному лекарственному обеспечению пациентов со злокачественными новообразованиями //Общественное здоровье и здравоохранение. 2023. № 2. С. 32-36.) doi: 10.56685/18120555_2023_76_1_32
4. Petrov AG, Khoroshilova OV, Filimonov SN, Semenikhin VA. Methodological foundations of the organization of specialized pharmaceutical care for patients with socially significant diseases. Medicine in Kuzbass. 2025; 24(1): 77-82. Russian (Петров А.Г., Хорошилова О.В., Филимонов С.Н., Семенихин В.А. Методологические основы организации специализированной фармацевтической помощи больным с социально-значимыми заболеваниями //Медицина в Кузбассе. 2025. Т. 24, № 1. С. 77-82.) doi: 10.24412/2687-0053-2025-1-77-82.
5. Telnova EA, Zagoruychenko AA. On the state of preferential drug provision. Bulletin of the National Scientific Research Institute of Public Health named after N.A. Semashko. 2021; 2: 72-81. Russian (Тельнова Е.А., Загоруйченко А.А. О состоянии льготного лекарственного обеспечения //Бюллетень Национального научно-исследовательского института общественного здоровья имени Н.А. Семашко. 2021. № 2. С. 72-81.) doi: 10.25742/NRIPH.2021.02.009
6. Tychino ES. Problemny`e voprosy` realizacii prava grazhdan na l`gotnoe lekarstvennoe obespechenie. Molodoj ucheny`j. 2024; 50(549): 396-399. Russian (Тычино Е.С. Проблемные вопросы реализации права граждан на льготное лекарственное обеспечение //Молодой ученый. 2024. № 50(549). С. 396-399.)
7. Shvets YuYu, Kostina AA. Drug supply as an element of medical care. Matters of Russian and International Law. 2024; 14(4A): 187-193. Russian (Швец Ю.Ю., Костина А.А. Лекарственное обеспечение как элемент медицинской помощи //Вопросы российского и международного права. 2024. Т. 14, № 4А. С. 187-193.)